New Novo Obesity Drug More Effective Than Wegovy

Published on March 7, 2024

Novo Nordisk said on Thursday early trial data for its highly anticipated experimental obesity drug amycretin showed a higher weight loss compared with its popular Wegovy treatment, sending its shares to new record highs. A Phase I trial of amycretin pill version showed…

Read Full Article (External Site)